The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

Trump's Tariff Vision: A Risky Prescription for Soaring Drug Costs and Shaken Supply Chains

Eli Lilly Declares UK 'Worst in Europe' for Drug Prices, Threatening Patient Access to New Medicines

Historic Triumph for American Patients: Pharma Giant Levels Drug Prices Across US and Europe Following Trump's Relentless Advocacy

WHO's Landmark Move: Adding Diabetes and Weight Loss Drugs to Essential Medicines List Sparks Hope and Debate

The GLP-1 Dilemma: Insurers Grapple with Soaring Costs, Eyeing New Strategies for Patient Care

Life-Saving Cancer Drugs Out of Reach: India's Price Control Gap Leaves Patients Vulnerable